Acquisition Synergies Reaxis was acquired by TIB Chemicals AG in February 2025, creating an opportunity to align product portfolios and leverage TIB's global network to cross-sell specialty chemicals and catalysts across existing and new markets.

Catalyst Opportunity The launch of REAXIS C3002EXP signals strength in specialty catalysts; target manufacturers requiring delayed-action iron carboxylate catalysts, offering value through co-development, customization, and bundled catalyst and technical support services.

Sustainability Edge Reaxis aims to meet international environmental and quality standards, positioning them for buyers with strict compliance needs and green chemistry initiatives, with opportunities to sell sustainable materials and provide audit-ready documentation.

Mid-market Advantage With 51-200 employees and revenue in the mid tens of millions, Reaxis fits well for contract manufacturing, toll processing, or scalable supply agreements, and can be positioned to expand through the new ownership under TIB.

Digital Readiness A tech stack featuring HubSpot Analytics and WordPress enables targeted inbound outreach and digital procurement options; propose a supplier portal, digital catalogs, COAs, and e-sourcing to streamline purchasing.